Central European Journal of Urology最新文献

{"title":"Estimated prediction of urinary tract neoplasms using the identify risk calculator in patients with haematuria.","authors":"Beatriz Gutiérrez Hidalgo, Juan Gómez Rivas, Irene de la Parra, Rommel Arévalo, M Isabel Galante Romo, Marco Ciappara, Enrique Redondo, Jesús Moreno-Sierra","doi":"10.5173/ceju.2024.0113","DOIUrl":"https://doi.org/10.5173/ceju.2024.0113","url":null,"abstract":"<p><strong>Introduction: </strong>The classification of patients studied for haematuria into risk groups is important for early diagnosis of urinary tract cancers and optimising healthcare resources. This study aims to evaluate the role of the IDENTIFY calculator in the initial study of these patients and its use for classifying patients into risk groups.</p><p><strong>Material and methods: </strong>A study of patients with haematuria was performed from June 2020 to June 2022. They were classified into risk groups using the IDENTIFY calculator. Final diagnosis of bladder neoplasia between the risk groups was compared. Receiver operating characteristic (ROC) curves were calculated according to the percentage of risk obtained with the calculator and the final diagnosis of bladder neoplasia.</p><p><strong>Results: </strong>We included 255 patients. Imaging tests were positive for bladder cancer in 39 patients (15.3%). Transurethral resection of bladder tumour was performed in 39 cases; 4 were negative, 18 cases Ta, 2 cases T1, 14 cases T2, and one case carcinoma <i>in situ</i> (CIS). The final diagnosis was bladder neoplasia in 35 patients (13.8%). These patients were classified as: one low risk (2.9%), 4 intermediate risk (11.4%), and 30 high risk (85.7%); p <0.001. ROC curves were calculated, with an AUC (area under curve) of 0.89; p <0.001.</p><p><strong>Conclusions: </strong>Patients classified into the high-risk group were more frequently diagnosed with bladder cancer than other risk groups. The IDENTIFY risk calculator is a simple and easy-to-use tool with acceptable discrimination in the diagnosis of urinary tract tumours, specifically bladder cancer.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 4","pages":"612-617"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Differential performance of imaging modalities predicting pathological response to neoadjuvant chemotherapy in urothelial bladder cancer: a systematic review and meta-analysis.","authors":"Mehdi Kardoust Parizi, Vitaly Margulis, Nirmish Singla, Akihiro Matsukawa, Arman Alimohammadi, Jakob Klemm, Ichiro Tsuboi, Tamás Fazekas, Marcin Miszczyk, Ekaterina Laukhtina, Shahrokh F Shariat","doi":"10.5173/ceju.2024.73","DOIUrl":"10.5173/ceju.2024.73","url":null,"abstract":"<p><strong>Introduction: </strong>We assessed the differential performance of imaging modalities predicting pathological response to neoadjuvant chemotherapy (NAC) in urothelial bladder cancer (UBC).</p><p><strong>Material and methods: </strong>Literature search was conducted using the MEDLINE, SCOPUS, and Cochrane Library in December 2023 to identify eligible studies.</p><p><strong>Results: </strong>Twenty-two studies comprising 1085 patients were selected. The pooled diagnostic odds ratio (DOR), positive likelihood ratio (LR), and negative LR of FDG positron emission tomography-computed tomography (PET/CT) for predicting bladder tumor complete pathological response (CPR) were 17.33 (95% CI: 1.65-180.99), 2.80 (95% CI: 1.04-7.57), and 0.16 (95% CI: 0.02-0.90), respectively. The pooled DOR, positive LR, and negative LR of FDG- PET/CT for predicting lymph node CPR were 5.25 (95% CI: 2.77-9.93), 1.62 (95% CI: 1.20-2.19), and 0.30 (95% CI: 0.22-0.43), respectively. The pooled DOR, positive LR, and negative LR of contrast enhanced magnetic resonance imaging (CEMRI) for predicting bladder tumor CPR were 153 (95% CI: 26.29-890.1), 16.20 (95% CI: 4.19-62.54), and 0.10 (95% CI: 0.04-0.26), respectively. The pooled DOR, positive LR, and negative LR of CEMRI for predicting lymph node CPR were 13.33 (95% CI: 1.06-166.37), 5.62 (95% CI: 0.82-38.53), and 0.42 (95% CI: 0.16-1.06), respectively.</p><p><strong>Conclusions: </strong>We demonstrated that CEMRI (including mpMRI) helps accurate assessment of response to NAC in UBC. While CEMRI is a useful tool to detect residual tumor in lymph nodes, contrast enhanced CT scan and FDG-PET/CT are precise staging modality to identify nodal metastasis responders to NAC. Nevertheless, this differential diagnostic performance needs to be further refined with radiomics and novel tracers to help individualized clinical decision-making.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 3","pages":"436-446"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"MRI-derived PRECISE score for predicting pathologically-confirmed progression in prostate cancer patients on active surveillance.","authors":"Filippo Carletti, Filippo Crimì, Gianmarco Randazzo, Giuseppe Reitano, Giovanni Basso, Ermanno Maria Segreto, Salvatore Carrozza, Francesca Sattin, Matteo Todisco, Giovanni Betto, Giacomo Novara, Fabrizio Dal Moro, Fabio Zattoni","doi":"10.5173/ceju.2024.59","DOIUrl":"10.5173/ceju.2024.59","url":null,"abstract":"<p><strong>Introduction: </strong>The utilization of magnetic resonance imaging (MRI) in active surveillance (AS) of prostate cancer (PCa) remains a topic of debate. The Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) scoring system is used to evaluate the progression of MRI lesions in men undergoing AS.This study aims to evaluate the predictive capacity of the PRECISE score in monitoring PCa patients on AS.</p><p><strong>Material and methods: </strong>A cohort of 63 men enrolled in an AS program between 2017 and 2021 was analyzed. Sequential MRIs within the AS protocol were assessed by a specialized radiologist using the PRECISE score. Data on biopsy outcomes, pathological progression, and treatment progression were documented. The relationship between progression and the PRECISE score was examined. Univariate logistic and Cox regression analyses were conducted to determine the baseline clinical and mpMRI parameters associated with disease progression.</p><p><strong>Results: </strong>The cohort exhibited ISUP progression and biopsy progression rates of 27.6% (16/63) and 48.3% (28/63), respectively. At the second MRI, a PRECISE score exceeding 3 was observed in 31 patients (53.4%), with 25 patients (43.1%) showing new lesions. Overall, 23 patients (39.7%) underwent active treatment during a median follow-up of 117 months. The PRECISE score emerged as the sole predictor, in univariate analysis, of ISUP progression (OR: 3.2, IQR: 1.1-9.7, p = 0.04), biopsy progression (OR: 3.2, IQR: 1.1-9.7, p = 0.03), and active treatment (HR: 1.1, IQR: 1.0-1.6, p = 0.05).</p><p><strong>Conclusions: </strong>The PRECISE scoring system facilitates the identification of patients at risk of ISUP and biopsy progression within an AS protocol utilizing mpMRI. These findings underscore the significance of mpMRI in AS.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 3","pages":"398-402"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Profiles of urinal exosomal miRNAs derived from bladder cancer.","authors":"Ērika Bitiņa-Barlote, Juris Plonis, Margarita Andrejeva, Egils Vjaters, Jānis Gardovskis, Zanda Daneberga, Edvīns Miklaševičs, Miki Nakazawa-Miklaševiča","doi":"10.5173/ceju.2023.279.R1","DOIUrl":"10.5173/ceju.2023.279.R1","url":null,"abstract":"<p><strong>Introduction: </strong>Exosomes contain nucleic acids and proteins inside of them. These are suggested as cell-cell communication materials and it is considered that they can modulate the status of other cells.</p><p><strong>Material and methods: </strong>To understand the bladder cancer (BC) related exosomal microRNAs (miRNAs), we compared the 752 urine exosomal miRNAs in healthy control (n = 7), low grade (LG) BC (n = 6) and high grade (HG) BC (n = 6) by RT-qPCR.</p><p><strong>Results: </strong>The differential expressing (DE) urine exosomal miRNAs (2 > fold regulation) were 96 and 78 in LG and HG, respectively. Our exosomal miRNAs profiles cover many miRNAs which have been reported in BC patients' tissues and other biofluids. Most DE exosomal miRNAs were up-regulated in the profiles. Seven up-regulated exosomal miRNAs in the LG group (miR-28-5p, miR-16-5p, miR-28-3p, miR-24-3p, miR-25-3p, miR-19b-3p and miR10b-5p) and 3 miRNAs in the HG group (miR-150-5p, miR-28-5p and miR28-3p) were found as directly <i>TP53</i> targeting. Twenty-two and 18 <i>PTEN</i> targeting miRNAs were observed in up-regulated miRNAs of LG and HG. The target genes of these exosomal miRNAs and their interaction network predicted that the <i>TP53</i> is the strongest hub gene in both BC groups exosomal miRNA networks. Several DE miRNAs were found that could potentially be used as biomarkers for the diagnosis of BC.</p><p><strong>Conclusions: </strong>Profiles of urinal exosomal miRNAs derived from BC manifested potentially epigenetic regulation of the <i>TP53</i> and <i>PTEN</i> genes as compared to other oncogenes and tumour suppressors.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 3","pages":"361-374"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921953/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Supine percutaneous nephrolithotomy in horseshoe kidney.","authors":"Silvia Proietti, Salvatore Di Pietro, Mon Mon Oo, Stefano Gisone, Riccardo Scalia, Franco Gaboardi, Guido Giusti","doi":"10.5173/ceju.2024.8","DOIUrl":"https://doi.org/10.5173/ceju.2024.8","url":null,"abstract":"<p><strong>Introduction: </strong>Historically, percutaneous nephrolithotomy (PCNL) in horseshoe kidney (HSK) patients has been performed in the prone position. Nevertheless, thanks to the spread of the supine PCNL technique for patients with urinary stones and normal renal anatomy, some retrospective studies have already reported on supine PCNL and HSK, showing the effectiveness and safety of the procedure. Herein we report our experience with supine PCNL in a subset of patients with urolithiasis.</p><p><strong>Material and methods: </strong>Prospective data were collected for all HSK patients who underwent supine PCNL at our institution from June 2016 to June 2023. Stone volume was reported as the volume of a single stone or the sum of the volumes of multiple stones on computed tomography (CT) images. Patients were reported to be stone-free if there were no stones on postoperative non-contrast CT (NCCT) exam. Peri-/postoperative complications were reported according to the Clavien-Dindo classification system. The primary endpoint of the study was stone-free rate (SFR) and the secondary endpoints were Clavien-Dindo complications Grade I or higher.</p><p><strong>Results: </strong>A total of 35 patients met the inclusion criteria and were enrolled in the study. Forty-eight procedures were analyzed. SFR was 72.9% at 1-month follow-up. In 11 out of 48 procedures (22.9%) Clavien-Dindo Grade I-II complications were recorded. In one case Clavien-Dindo Grade IIIa complication was observed.</p><p><strong>Conclusions: </strong>In this prospective study of 35 HSK patients who underwent 48 procedures, supine PCNL was safe and effective, with minimal morbidity.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 2","pages":"291-297"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and efficacy of non-surgical treatments for chronic post-radiation cystitis: a systematic review.","authors":"Nikolaos Datseris, Theodoros Gkazis, Spyridon Nikas, Dimitrios Memmos, Eirini Zoumpanioti, Petros Sountoulides","doi":"10.5173/ceju.2024.116.R2","DOIUrl":"10.5173/ceju.2024.116.R2","url":null,"abstract":"<p><strong>Introduction: </strong>Post-radiation cystitis is a complication of external beam radiation therapy, for the radical treatment of pelvic malignancies as radical treatment for pelvic malignancies. Chronic, refractory, post-radiation cystitis is problematic in its management, mainly when a conservative approach is preferred. Conservative methods are the first line of treatment, especially since the area has been irradiated, making surgical treatment more challenging.The objective of this systematic review is to evaluate the effectiveness and safety of conservative methods for the management of post-radiation cystitis. All non-invasive methods were included in the research, in patients over 18 years of age undergoing pelvic radiation therapy.</p><p><strong>Material and methods: </strong>We conducted a systematic search for comparable studies on the conservative treatment of chronic post-radiation cystitis, analysing the efficacy and safety of these techniques, based on a specific protocol. The PubMed, Scopus, and CENTRAL databases and the grey literature were searched. Risk control of the individual papers was carried out using the RoB2 and ROBINS-I tools.</p><p><strong>Results: </strong>A total of 282 papers were reviewed, of which 6 were included in the review: 3 randomised clinical trials and 3 non-randomised studies. Each of these studies investigated a different treatment, using a different population as control group, so it was not possible to conduct a meta-analysis of the studies.</p><p><strong>Conclusions: </strong>Although most conservative measures appear to be successful in the management of post-radiation cystitis, more studies, especially randomised clinical trials, are needed before an algorithm of conservative methods can be created.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 3","pages":"472-482"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921955/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of obesity on peri-operative and functional outcomes after robotic-assisted simple prostatectomy.","authors":"Alfredo Maria Bove, Rigoberto Pallares-Mendez, Mario Ochoa, Aldo Brassetti, Simone D'Annunzio, Leonardo Misuraca, Gabriele Tuderti, Umberto Anceschi, Riccardo Mastroianni, Mariaconsiglia Ferriero, Rocco Simone Flammia, Flavia Proietti, Costantino Leonardo, Giuseppe Simone","doi":"10.5173/ceju.2024.77","DOIUrl":"10.5173/ceju.2024.77","url":null,"abstract":"<p><strong>Introduction: </strong>Obesity represents a worldwide epidemic disorder, increasing the overall morbidity and mortality rate. In this study we assessed the impact of obesity on perioperative and long-term functional outcomes of robotic-assisted simple prostatectomy (RASP).</p><p><strong>Material and methods: </strong>Baseline measurements of uroflowmetry and validated questionnaire responses were prospectively recorded, which were repeated at follow-up. Composite outcomes (trifecta) were defined as combination of post-operative Q-max >15 ml/s, IPSS score <8, and absence of complications. Pentafecta included 2 additional criteria, namely post-operative ejaculation persistence (MSHQ score >0) and erectile function maintenance (ΔIEEF <6). Data analysis was stratified by BMI (<30 or ≥30).</p><p><strong>Results: </strong>Eighty-one patients underwent RASP in our institution. Baseline demographic and clinical features, questionnaire scores, and baseline uroflowmetry results showed no significant differences between obese and non-obese cohorts. However, during follow-up, obese patients reported less improvement in IPSS (p = 0.02) and OABQ scores (p <0.001), along with a higher incidence of stress incontinence requiring duloxetine (p <0.001). Uroflowmetry outcomes were also lower in the obesity group (p = 0.02 and p = 0.03 for Qmax [ml/s] and post-void residual [ml], respectively). However, when considering assessment of comprehensive outcomes, obese patients demonstrated similar rates of achieving trifecta (67% vs 54%, p = 0.39) and pentafecta (p = 0.76) compared to non-obese patients.</p><p><strong>Conclusions: </strong>Our results show that obesity is associated with poorer functional outcomes. Specifically concerning storage LUTS and incontinence rates following RASP. However, no impact of obesity on the achievement rates of trifecta and pentafecta outcomes was observed.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 3","pages":"460-465"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum: Hijazi S, Synoverskyy P, Karapanos L, et al. Efficacy of botulinum toxin in the management of refractory de novo overactive bladder symptoms in women after midurethral sling placement: retrospective, single center study.","authors":"","doi":"10.5173/ceju.2024.01.ER","DOIUrl":"10.5173/ceju.2024.01.ER","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.5173/ceju.2023.273.].</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 3","pages":"570"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ready for transition to adult care? Validation of the Polish version of the Transition Readiness Assessment Questionnaire for adolescents with spina bifida (TRAQ-SB).","authors":"Barbara Dobrowolska-Glazar, David Wood, Wojciech Górecki, Edyta Mazurek, Aneta Cygan, Rafał Chrzan","doi":"10.5173/ceju.2024.0149","DOIUrl":"https://doi.org/10.5173/ceju.2024.0149","url":null,"abstract":"<p><strong>Introduction: </strong>Guidelines for transition from paediatric to adult care are being introduced around the world. There are tools available in the English-language literature to assess a patient's readiness to transition. The aim of the study was to adapt the English-language version of the Transition Readiness Assessment Questionnaire for patients with spina bifida (TRAQ-SB).</p><p><strong>Material and methods: </strong>The questionnaire was translated into Polish following the established procedure. Two native Polish speakers who declared a very good command of English translated the TRAQ-SB into Polish. Then, 2 native English speakers who declared fluency in Polish and who did not know the content of the original questionnaire, independently translated it back into English. The outcome was assessed and the discrepancies related to different healthcare systems were corrected and approved with the author of the TRAQ-SB. The TRAQ-SB-PL scale was also checked for reliability, construct validity, and internal consistency in a pilot study. Fifty-two spina bifida patients aged 13 to 18 years were recruited.</p><p><strong>Results: </strong>Static analysis revealed a 3-domain structure of the 26-item version of the TRAQ-SB-PL: \"Autonomy\", \"Health literacy\", and \"Adherence\". The internal consistency of the total score was good (0.734). Age had a significant effect on the TRAQ-SB-PL-26 score. There was no statistically significant difference between girls and boys.</p><p><strong>Conclusions: </strong>The TRAQ-SB-PL-26 is a reliable tool that can also be used in the Polish population. It will help to identify teenagers who need more attention during the transition process. The survey will raise awareness of the transition and may be used for educational purposes.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 4","pages":"649-657"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143984263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"LUTS POLAND: The first population-based study of prevalence, bother, and treatment-related behaviour for lower urinary tract symptoms and overactive bladder in Eastern Europe.","authors":"Mikolaj Przydacz, Piotr Chlosta","doi":"10.5173/ceju.2024.0233","DOIUrl":"https://doi.org/10.5173/ceju.2024.0233","url":null,"abstract":"","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 4","pages":"658-660"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143973666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}